German minimally invasive spine device company joimax reported 31 percent sales growth in 2016 over the previous year.
The company is active in 45 countries, with a strongest reputation in Europe and Asia and a growing presence in the United States. "The entry in force of the CPT 2017 reimbursement codebook as of Jan. 1, 2017 is a milestone towards the full acceptance of endoscopic minimally invasive spine surgery techniques," said Founder and CEO Wolfgang Ries.
The new codebook contains the first endoscopic spine surgery code for transforaminal and/or interlaminar procedures, which the company's TESSYS and iLESSYS cover. The company received 18 patents and patent publications last year, bringing their total patents and trademarks to 150.
The company's EndoLIF Cage was introduced for minimally invasive and open transforaminal lumbar interbody fusion and the company expects to innovate with new implants based on the EndoLIF technology in the future. The company will also focus on decompression methods based on endoscopic systems.